SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-14-040515
Filing Date
2014-11-06
Accepted
2014-11-06 16:25:46
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 RAPTOR PHARMACEUTICAL CORP 10-Q 9-30-2014 from10q.htm 10-Q 755696
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 9080
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 9055
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 8437
11 image00018.jpg GRAPHIC 1667
  Complete submission text file 0001140361-14-040515.txt   5557769

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rptp-20140930.xml EX-101.INS 759680
6 XBRL TAXONOMY EXTENSION SCHEMA rptp-20140930.xsd EX-101.SCH 40062
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rptp-20140930_cal.xml EX-101.CAL 56032
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rptp-20140930_def.xml EX-101.DEF 151135
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptp-20140930_lab.xml EX-101.LAB 552794
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptp-20140930_pre.xml EX-101.PRE 301418
Mailing Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949
Business Address 7 HAMILTON LANDING SUITE 100 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-25571 | Film No.: 141201048
SIC: 2834 Pharmaceutical Preparations